Cargando…
Study protocol: combined N-of-1 trials to assess open-label placebo treatment for antidepressant discontinuation symptoms [FAB-study]
BACKGROUND: Antidepressant discontinuation is associated with a broad range of adverse effects. Debilitating discontinuation symptoms can impede the discontinuation process and contribute to unnecessary long-term use of antidepressants. Antidepressant trials reveal large placebo effects, indicating...
Autores principales: | Müller, Amke, Konigorski, Stefan, Meißner, Carina, Fadai, Tahmine, Warren, Claire V., Falkenberg, Irina, Kircher, Tilo, Nestoriuc, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576328/ https://www.ncbi.nlm.nih.gov/pubmed/37833651 http://dx.doi.org/10.1186/s12888-023-05184-y |
Ejemplares similares
-
Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial
por: Meißner, Carina, et al.
Publicado: (2023) -
Physicians’ beliefs about placebo and nocebo effects in antidepressants – an online survey among German practitioners
por: Kampermann, Lea, et al.
Publicado: (2017) -
The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design
por: Falkenberg, Irina, et al.
Publicado: (2023) -
Open-label placebos for menopausal hot flushes: a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2020) -
“Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2022)